Toremifene citrate
Toremifene citrate | |
---|---|
Term | Toremifene citrate |
Short definition | toremifene citrate - (pronounced) (tor-EH-mih-feen SIH tray) drug used to treat postmenopausal women with breast cancer that has spread to other parts of the body. It is used in patients whose cancer is estrogen receptor positive (ER+) or when it is not known whether the cancer is ER+ or estrogen receptor negative (ER-). |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
toremifene citrate - (pronounced) (tor-EH-mih-feen SIH tray) drug used to treat postmenopausal women with breast cancer that has spread to other parts of the body. It is used in patients whose cancer is estrogen receptor positive (ER+) or when it is not known whether the cancer is ER+ or estrogen receptor negative (ER-). Toremifene citrate blocks the effects of the hormone estrogen in breast tissue, which may help prevent breast cancer cells from growing. It is a type of Selective Estrogen Receptor Modulator (SERM). Also called Fareston
External links
- Medical encyclopedia article on Toremifene citrate
- Wikipedia's article - Toremifene citrate
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski